Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001664710-24-000017
Filing Date
2024-02-28
Accepted
2024-02-28 16:05:39
Documents
111
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kros-20231231.htm   iXBRL 10-K 1833938
2 EX-4.3 exhibit4310-kfy2023.htm EX-4.3 23236
3 EX-10.12 exhibit1012fy2023.htm EX-10.12 19290
4 EX-21.1 exhibit21110-kfy2023.htm EX-21.1 3563
5 EX-23.1 exhibit23110-kfy2023.htm EX-23.1 2156
6 EX-31.1 exhibit31110-kfy2023.htm EX-31.1 17393
7 EX-31.2 exhibit31210-kfy2023.htm EX-31.2 17274
8 EX-32.1 exhibit32110-kfy2023.htm EX-32.1 9857
9 EX-97 exhibit9710-kfy2023.htm EX-97 41129
15 kros-20231231_g1.jpg GRAPHIC 83551
16 kros-20231231_g10.jpg GRAPHIC 1655832
17 kros-20231231_g11.jpg GRAPHIC 1251532
18 kros-20231231_g12.jpg GRAPHIC 1132300
19 kros-20231231_g13.jpg GRAPHIC 91769
20 kros-20231231_g14.jpg GRAPHIC 212834
21 kros-20231231_g15.jpg GRAPHIC 38045
22 kros-20231231_g16.jpg GRAPHIC 51244
23 kros-20231231_g17.jpg GRAPHIC 98658
24 kros-20231231_g18.jpg GRAPHIC 86298
25 kros-20231231_g19.jpg GRAPHIC 73615
26 kros-20231231_g2.jpg GRAPHIC 249520
27 kros-20231231_g20.jpg GRAPHIC 645028
28 kros-20231231_g21.jpg GRAPHIC 51441
29 kros-20231231_g22.jpg GRAPHIC 73343
30 kros-20231231_g23.jpg GRAPHIC 36991
31 kros-20231231_g24.jpg GRAPHIC 154288
32 kros-20231231_g25.jpg GRAPHIC 185697
33 kros-20231231_g26.jpg GRAPHIC 147432
34 kros-20231231_g27.jpg GRAPHIC 225339
35 kros-20231231_g28.jpg GRAPHIC 198078
36 kros-20231231_g29.jpg GRAPHIC 123743
37 kros-20231231_g3.jpg GRAPHIC 69632
38 kros-20231231_g30.jpg GRAPHIC 94931
39 kros-20231231_g31.jpg GRAPHIC 536089
40 kros-20231231_g4.jpg GRAPHIC 188134
41 kros-20231231_g5.jpg GRAPHIC 238848
42 kros-20231231_g6.jpg GRAPHIC 249607
43 kros-20231231_g7.jpg GRAPHIC 328227
44 kros-20231231_g8.jpg GRAPHIC 1096110
45 kros-20231231_g9.jpg GRAPHIC 1914676
  Complete submission text file 0001664710-24-000017.txt   35690986

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20231231.xsd EX-101.SCH 42812
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kros-20231231_cal.xml EX-101.CAL 77041
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20231231_def.xml EX-101.DEF 179498
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20231231_lab.xml EX-101.LAB 634602
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20231231_pre.xml EX-101.PRE 395837
113 EXTRACTED XBRL INSTANCE DOCUMENT kros-20231231_htm.xml XML 737553
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39264 | Film No.: 24695214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)